A survey of the breast cancer cell lines MCF-7 and MDA-MB-231 revealed that hyperinsulinemia, not hyperglycemia, drives the activity of the HIF-1α rather than the one-way regulatory mechanism between HIF and glucose [45]. Here, HIF1A is linked to breast carcinoma.